DOJ Takes Aim At Actavis’ Drug-Making Practices

Law360, New York (November 17, 2008, 12:00 AM EST) -- The U.S. Department of Justice has targeted two U.S. subsidiaries of Iceland-based generic-drug maker Actavis Group in a suit alleging that a series of regulatory inspections have turned up problems with company manufacturing practices.

The government said Friday it lodged the suit in the U.S. District Court for the District of New Jersey against Actavis Inc., Actavis Totowa LLC and two of their officers and is seeking a permanent injunction to block them from making and distributing generic drugs until they show that they are able...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.